Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven J Berberich

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Sub-Cellular Biochemistry|September 10, 2014
Mdm2 and MdmX involvement in human cancerSteven J Berberich
Cell Cycle (Georgetown, Tex.)|September 22, 2010
RNAi knockdown of HdmX or Hdm2 leads to new insights into p53 signalingSteven J Berberich
Oncogene|June 25, 2002
Mdm2 inhibition of p53 induces E2F1 transactivation via p21Mark Wunderlich, Steven J Berberich
American Journal of Cancer Research|July 12, 2011
FHIT gene expression is repressed by mitogenic signaling through the PI3K/AKT/FOXO pathwayKevin Kelley, Steven J Berberich
Cell Cycle (Georgetown, Tex.)|May 7, 2005
MdmX inhibits ARF mediated Mdm2 sumoylationMithua Ghosh, Karen Weghorst, Steven J Berberich
Biochemistry|February 26, 2003
Overexpression of Mdm2 and MdmX fusion proteins alters p53 mediated transactivation, ubiquitination, and degradationMithua Ghosh, Keven Huang, Steven J Berberich
Frontiers in Bioscience (Landmark Edition)|January 4, 2011
Why YPEL3 represents a novel tumor suppressorSteven J Berberich, Amber Todd, Rebecca Tuttle
The Annals of Thoracic Surgery|September 26, 2006
Invited commentaryDouglas E Paull, Katherine Heminger, Steven J Berberich
Cell Cycle (Georgetown, Tex.)|January 24, 2004
MdmX represses E2F1 transactivationMark Wunderlich, Mithua Ghosh, Karen Weghorst, et al.
Aging|December 1, 2009
Alterations in gene expression and sensitivity to genotoxic stress following HdmX or Hdm2 knockdown in human tumor cells harboring wild-type p53Katherine Heminger, Michael Markey, Meldrick Mpagi, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Sub-Cellular Biochemistry|September 10, 2014
Mdm2 and MdmX involvement in human cancerSteven J Berberich
Cell Cycle (Georgetown, Tex.)|September 22, 2010
RNAi knockdown of HdmX or Hdm2 leads to new insights into p53 signalingSteven J Berberich
Oncogene|June 25, 2002
Mdm2 inhibition of p53 induces E2F1 transactivation via p21Mark Wunderlich, Steven J Berberich
American Journal of Cancer Research|July 12, 2011
FHIT gene expression is repressed by mitogenic signaling through the PI3K/AKT/FOXO pathwayKevin Kelley, Steven J Berberich
Cell Cycle (Georgetown, Tex.)|May 7, 2005
MdmX inhibits ARF mediated Mdm2 sumoylationMithua Ghosh, Karen Weghorst, Steven J Berberich
Biochemistry|February 26, 2003
Overexpression of Mdm2 and MdmX fusion proteins alters p53 mediated transactivation, ubiquitination, and degradationMithua Ghosh, Keven Huang, Steven J Berberich
Frontiers in Bioscience (Landmark Edition)|January 4, 2011
Why YPEL3 represents a novel tumor suppressorSteven J Berberich, Amber Todd, Rebecca Tuttle
The Annals of Thoracic Surgery|September 26, 2006
Invited commentaryDouglas E Paull, Katherine Heminger, Steven J Berberich
Cell Cycle (Georgetown, Tex.)|January 24, 2004
MdmX represses E2F1 transactivationMark Wunderlich, Mithua Ghosh, Karen Weghorst, et al.
Aging|December 1, 2009
Alterations in gene expression and sensitivity to genotoxic stress following HdmX or Hdm2 knockdown in human tumor cells harboring wild-type p53Katherine Heminger, Michael Markey, Meldrick Mpagi, et al.
Pageof 2